LATEST PRESS RELEASES

550 views6 min read

MINDCURE Welcomes Dr. Ken Weingardt, Digital Therapy Visionary, as a Senior Clinical Technology Advisor to its Psychedelic Digital Therapeutics Team

Mind Cure Health
Dr. Weingardt, a clinical psychologist and previously a Senior Clinical Director at Pear Therapeutics will guide MINDCURE's digital therapeutics technology (DTx) platform, iSTRYM, through near-term commercial deployment VANCOUVER, BC, Aug. 10, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in adv... Read More...
136 views9 min read

PharmaDrug Forms Research Collaboration with Terasaki Institute for Novel Ocular Drug Formulation Program to Deliver DMT and Other Tryptamines to Treat Eye Disease

Pharmadrug
Unlocking the potential of psychedelics, including DMT, and other tryptamines to treat the significant unmet medical needs of glaucoma patientsPartnering with world-renowned research institution brings validated drug delivery expertise in novel, controlled drug-release technologiesToronto, Ontario--(Newsfile Corp. - August 5, 2021) - Phar... Read More...
880 views3 min read

Pure Extracts Ships Initial Edible Cannabis Gummies Order to British Columbia

Pure Extracts Technologies
VANCOUVER, British Columbia, Aug. 05, 2021 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp and the rapidly emerging psychedelic sector, is pleased to announce that its wholly owned subsidiary, Pure Extracts Manufactur... Read More...
CalendarFinancials52 views1 min read

COMPASS Pathways plc to announce second quarter 2021 financial results on 11 August 2021

COMPASS Pathways plc
London, UK, Aug. 04, 2021 -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health, announced today that it will release financial results for the second quarter 2021, and provide an update on recent business developments, on 11 August 2021.... Read More...
63 views4 min read

Cybin to Commence Trading on the NYSE American on August 5

Cybin
TORONTO, August 04, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB:CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that its common shares will open for trading on the NYSE American LLC stock exchange ("NYSE American") on August 5, 2021, under the symbol "CYBN... Read More...
1225 views4 min read

MINDCURE Appoints Jerry White, Award-Winning Humanitarian Activist Who Shares in the 1997 Nobel Peace Prize, as Company Advisor

Mind Cure Health
The recipient of numerous human rights and leadership awards, Mr. White will assist MINDCURE on its mission to revolutionize mental health treatments through the development and scaling of science-backed psychedelic medicines globally. VANCOUVER, BC, Aug. 4, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE"), ... Read More...
52 views5 min read

Cybin Announces Closing of Overnight Marketed Public Offering of Common Shares and Exercise of Over-Allotment Option

Cybin
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, August 03, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO:CYBN) (OTCQB: CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, is pleased to announce that it has closed its previously announced over... Read More...
75 views7 min read

Allied Corp Initiates Additional Commercial CBD Shipment From Colombia Destined for Colorado, United States

Allied
KELOWNA, British Columbia, Aug. 03, 2021 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to announce that it has initiated its second commercial shipment of cannabidiol (“CBD”) (containin... Read More...
Financials125 views8 min read

Red Light Holland Signs Definitive Agreement with Mera Life Sciences and Files Annual Financial Statements

Red Light Holland
Toronto, Ontario--(Newsfile Corp. - July 30, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland"), an Ontario-based corporation engaged in the production, growth and sale of a premium brand of magic truffles, is pleased to announce that its financial results for the year ended March 31, 2021 ("FY2... Read More...
1491 views3 min read

Novamind Opens 5th Clinic Location Specialized in Integrative Psychiatry for Patients with Treatment-Resistant Conditions

Novamind
Company executes organic growth mandate, on track to open four new clinics by Q3 2021TORONTO, ON / ACCESSWIRE / July 29, 2021 / Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has completed the construction of a new clinic foc... Read More...
Financials1023 views10 min read

Numinus Wellness Closes Q3 2021 With $63.2 Million Cash Position, Lab and Trial Advances, and Strategic Expansion into Psychedelic Neurology

Numinus Wellness
VANCOUVER, BC, July 29, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a mental health care company advancing innovative treatments and safe, evidence-based psychedelic-assisted therapies, today announced its fiscal third quarter results ended May 31, 2021. In the third quarter, Numinus maintained a healthy cash position, achieve... Read More...
1173 views6 min read

The World’s Premiere Psychedelic and Wellness Event

Delic Holdings
As a lifelong advocate of holistic health, Aubrey is most passionate about raising awareness for the benefits of psychedelic medicine. "Psychedelic medicines have been an inexorable part of my story for the last 22 years. I'm looking forward to sharing more of my story with everyone at the Meet Delic event," stated Marcus. The experient... Read More...
74 views4 min read

Entheon Biomedical Further Strengthens Advisory Board with Appointment of Dr. Andy Greenshaw

Entheon Biomedical
Vancouver, British Columbia--(Newsfile Corp. - July 28, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is pleased to announce the addition of Dr. Andrew (Andy) Greenshaw, Professor of Psychiatry an... Read More...
92 views4 min read

Cybin Announces Size and Pricing of Previously Announced Overnight Marketed Public Offering of Common Shares

Cybin
NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATESTORONTO, July 28, 2021--(BUSINESS WIRE)--Cybin Inc. (NEO: CYBN) (OTCQB: CLXPF) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, announced today the pricing of its previously announced overnight market... Read More...
Calendar253 views4 min read

Field Trip Health Ltd. to Commence Trading on the NASDAQ on July 29, 2021 Under the Symbol FTRP

Field Trip Health
TORONTO, July 27, 2021 -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic therapies, announced today that it has received final approval from The NASDAQ Stock Market LLC (“NASDAQ”) to list its common shares on the NASDAQ Global Select... Read More...
1394 views1 min read

Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent

Silo Pharma
Central Nervous System Homing Peptide under development to deliver Psychedelics including Psilocybin Englewood Cliffs NJ, July 27, 2021 -- Silo Pharma, Inc. (OTCQB:SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announcedthat the United States Patent Office has issued a notic... Read More...
841 views4 min read

MINDCURE Launches Second Stage of Manufacturing Synthetic Ibogaine for Use in Psychedelic Clinical Research

Mind Cure Health
MINDCURE's pharmaceutical grade ibogaine would provide researchers access to a sustainable, high-quality, reliable, and consistent supply of the psychedelic drug. VANCOUVER, BC, July 27, 2021 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("MINDCURE"), a leader in advanced proprietary technology and research for psychedelic... Read More...
811 views7 min read

Allied Corp Commends the Colombian Authorities for Approving the Export of Dried Cannabis Flower From Colombia

Allied
KELOWNA, British Columbia, July 26, 2021 -- Allied Corp. ("Allied" or the “Company”) (OTCQB: ALID) an international medical company focused on creating and providing health solutions to address today’s medical mental health issues is pleased to commend the recent announcement made by the Colombian authorities allowing for the export of dr... Read More...
556 views4 min read

Field Trip Health Ltd. Obtains Conditional Approval to List on Nasdaq Under the Symbol “FTRP”

Field Trip Health
TORONTO, July 23, 2021 -- Field Trip Health Ltd. (TSX: FTRP; FTRP.WT; OTCQX: FTRPF) ("Field Trip" or the “Company”), a global leader in the development and delivery of psychedelic therapies, announced today that it has received conditional approval from The NASDAQ Stock Market LLC (“NASDAQ”) to list its issued and outstanding common share... Read More...
263 views9 min read

Meet DELIC, the Premiere Psychedelic and Wellness Edutainment Event and Expo for Newcomers and Veteran Psychonauts, Announces Initial Business Speaker Lineup

Delic Holdings
Leading Business and Entrepreneurial Voices Include Itefayo Harvey, Dina Burkitbayeva, Matt Zemon, Martin Tobias, George Goldsmith, Mark Goldfogel, Nanea Reeves, Katya Malievskaia, Dr. Jeff Chen, Ronan Levy, Jennifer Pereira, Barbara Branaman and Many Others to Take Part in First of its Kind Las Vegas Event November 6-7, 2021 Two-Day Exp... Read More...
1391 views3 min read

Novamind Has Applied to Have its Common Shares Posted for Trading on the OTCQB in the United States

Novamind
Aims to increase visibility and facilitate investment for United States investorsTORONTO, ON / ACCESSWIRE / July 21, 2021 /Novamind Inc. (CSE:NM)(OTC PINK:NVMDF)(FSE:HN2) ("Novamind"), a leading mental health company specialized in psychedelic medicine, is pleased to announce that it has submitted its application to have its common shares... Read More...
550 views4 min read

PharmaTher Expands Psychedelic Patent Portfolio with Filing of U.S. Patent Application for Novel Ketamine Formulation

PharmaTher Holdings
Strengthens position to become a leader in the intradermal delivery of FDA prescription-based ketamine productsSupports commercializing novel uses and delivery methods of psychedelics TORONTO, July 21, 2021 -- PharmaTher Holdings Ltd. (the “Company” or “PharmaTher”) (OTCQB: PHRRF) (CSE: PHRM), a clinical-stage psychedelics biotech company... Read More...
1256 views5 min read

Mydecine Expands Portfolio of Novel Molecules Filing New Patent for MDMA-like Compounds

Mydecine Innovations Group
DENVER, July 21, 2021 -- Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced medicine for mainstream use, today announced that the Company has filed a new patent fo... Read More...
M & A32 views6 min read

Red Light Holland Expected Merger Partner Creso Pharma Completes Acquisition of Halucenex Life Sciences Inc

Creso Pharma
Halucenex a key strategic asset for proposed merger between Red Light Holland and Creso Pharma to create The HighBrid LabToronto, Ontario--(Newsfile Corp. - July 15, 2021) - Red Light Holland Corp. (CSE: TRIP) (FSE: 4YX) (OTC Pink: TRUFF) ("Red Light Holland" or the "Company"), an Ontario-based corporation engaged in the production, growt... Read More...
31 views3 min read

Pure Extracts Signs Purchase Order with Private Saskatchewan Cannabis Distributor

Pure Extracts Technologies
VANCOUVER, British Columbia, July 15, 2021 -- Pure Extracts Technologies Corp. (CSE: PULL) (OTC: PRXTF) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company focused on cannabis, hemp, functional mushrooms and the rapidly emerging psychedelic sector, is pleased to announce that its wholly-owned subsidiary, Pu... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!